|
2024-03-27 |
2024-03-27 |
B
Purchase
|
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Officer
|
2,000
+16.7%
24.80
49,600
USD
|
2,000
+16.7%
|
24.80
|
49,600
USD
|
|
|
2024-03-25 |
2024-03-25 |
S
Sale
|
Radovich Peter
PRESIDENT AND COO
Officer
|
4,303
-12.9%
25.80
111,017
USD
|
4,303
-12.9%
|
25.80
|
111,017
USD
|
|
|
2024-03-18 |
2024-03-18 |
B
Purchase
|
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Officer
|
2,000
+20.0%
25.80
51,600
USD
|
2,000
+20.0%
|
25.80
|
51,600
USD
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Peetz Christopher
CHIEF EXECUTIVE OFFICER
Executive Director
|
6,013
-5.5%
26.19
157,491
USD
|
6,013
-5.5%
|
26.19
|
157,491
USD
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Radovich Peter
PRESIDENT AND COO
Officer
|
1,790
-4.9%
26.19
46,883
USD
|
1,790
-4.9%
|
26.19
|
46,883
USD
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Longpre Lara
CHIEF DEVELOPMENT OFFICER
Officer
|
847
-0.8%
26.19
22,184
USD
|
847
-0.8%
|
26.19
|
22,184
USD
|
|
|
2024-02-05 |
2024-02-02 |
S
Sale
|
Vig Pamela
CHIEF SCIENTIFIC OFFICER
Officer
|
1,214
-4.1%
26.19
31,797
USD
|
1,214
-4.1%
|
26.19
|
31,797
USD
|
|
|
2024-02-02 |
2024-02-02 |
S
Sale
|
Howe Jolanda
SVP, GLOBAL CONTROLLER
Officer
|
735
-29.5%
26.19
19,251
USD
|
735
-29.5%
|
26.19
|
19,251
USD
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Longpre Lara
CHIEF DEVELOPMENT OFFICER
Officer
|
1,019
-1.0%
28.04
28,568
USD
|
1,019
-1.0%
|
28.04
|
28,568
USD
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Peetz Christopher
PRESIDENT AND CEO
Executive Director
|
5,209
-4.5%
28.03
146,033
USD
|
5,209
-4.5%
|
28.03
|
146,033
USD
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Radovich Peter
CHIEF OPERATING OFFICER
Officer
|
1,408
-3.7%
28.03
39,473
USD
|
1,408
-3.7%
|
28.03
|
39,473
USD
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Howe Jolanda
SVP, GLOBAL CONTROLLER
Officer
|
528
-42.2%
28.04
14,803
USD
|
528
-42.2%
|
28.04
|
14,803
USD
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
Vig Pamela
HEAD OF RESEARCH & DEVELOPMENT
Officer
|
1,408
-4.5%
28.03
39,472
USD
|
1,408
-4.5%
|
28.03
|
39,472
USD
|
|
|
2023-12-06 |
2023-12-05 |
S
Sale
|
Howe Jolanda
SVP, Global Controller
Officer
|
2,500
-100.0%
32.40
81,000
USD
|
2,500
-100.0%
|
32.40
|
81,000
USD
|
|
|
2023-11-14 |
2023-11-09 |
B
Purchase
|
Heron Patrick J
Non-Executive Director
|
2,910
+1.8%
28.30
82,353
USD
|
2,910
+1.8%
|
28.30
|
82,353
USD
|
|
|
2023-09-14 |
2023-09-14 |
PS
Planned sale
|
GREY MICHAEL G
Non-Executive Director
|
14,216
-100.0%
32.00
454,912
USD
|
14,216
-100.0%
|
32.00
|
454,912
USD
|
|
|
2023-09-15 |
2023-09-13 |
B
Purchase
|
Heron Patrick J
Non-Executive Director
|
2,625
+1.7%
31.02
81,425
USD
|
2,625
+1.7%
|
31.02
|
81,425
USD
|
|
|
2023-09-14 |
2023-09-13 |
PS
Planned sale
|
GREY MICHAEL G
Non-Executive Director
|
392
-100.0%
32.00
12,544
USD
|
392
-100.0%
|
32.00
|
12,544
USD
|
|
|
2023-09-13 |
2023-09-12 |
B
Purchase
|
Heron Patrick J
Non-Executive Director
|
3,750
+2.5%
30.60
114,764
USD
|
3,750
+2.5%
|
30.60
|
114,764
USD
|
|
|
2023-09-13 |
2023-09-11 |
B
Purchase
|
Heron Patrick J
Non-Executive Director
|
4,687
+3.2%
30.30
142,027
USD
|
4,687
+3.2%
|
30.30
|
142,027
USD
|
|
|
2023-09-12 |
2023-09-11 |
B
Purchase
|
BJERKHOLT ERIC
Chief Financial Officer
Officer
|
10,000
+inf%
29.65
296,492
USD
|
10,000
+inf%
|
29.65
|
296,492
USD
|
|
|
2023-09-05 |
2023-08-31 |
B
Purchase
|
Heron Patrick J
Non-Executive Director
Major owner
|
147,991
+inf%
26.25
3,884,764
USD
|
147,991
+inf%
|
26.25
|
3,884,764
USD
|
|
|
2023-08-28 |
2023-08-25 |
S
Sale
|
Howe Jolanda
SVP, Global Controller
Officer
|
3,459
-100.0%
26.23
90,743
USD
|
3,459
-100.0%
|
26.23
|
90,743
USD
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Radovich Peter
Chief Operating Officer
Officer
|
1,425
-3.6%
25.65
36,546
USD
|
1,425
-3.6%
|
25.65
|
36,546
USD
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Howe Jolanda
SVP, Global Controller
Officer
|
915
-20.9%
25.65
23,467
USD
|
915
-20.9%
|
25.65
|
23,467
USD
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Peetz Christopher
President and CEO
Executive Director
|
5,498
-4.6%
25.65
141,005
USD
|
5,498
-4.6%
|
25.65
|
141,005
USD
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Vig Pamela
Head of Research & Development
Officer
|
1,425
-4.4%
25.65
36,546
USD
|
1,425
-4.4%
|
25.65
|
36,546
USD
|
|
|
2023-07-05 |
2023-07-03 |
S
Sale
|
Longpre Lara
Chief Development Officer
Officer
|
1,004
-0.9%
25.65
25,749
USD
|
1,004
-0.9%
|
25.65
|
25,749
USD
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
GREY MICHAEL G
Non-Executive Director
|
14,608
-100.0%
29.00
423,632
USD
|
14,608
-100.0%
|
29.00
|
423,632
USD
|
|
|
2023-05-04 |
2023-05-03 |
PS
Planned sale
|
GREY MICHAEL G
Non-Executive Director
|
14,608
-100.0%
28.00
409,024
USD
|
14,608
-100.0%
|
28.00
|
409,024
USD
|
|
|
2024-03-18 |
2023-01-09 |
S
Sale
|
Vig Pamela
CHIEF SCIENTIFIC OFFICER
Officer
|
1,379
-4.8%
20.62
28,438
USD
|
1,379
-4.8%
|
20.62
|
28,438
USD
|
|
|
2024-03-18 |
2023-01-09 |
S
Sale
|
Peetz Christopher
CHIEF EXECUTIVE OFFICER
Executive Director
|
5,159
-5.3%
20.62
106,390
USD
|
5,159
-5.3%
|
20.62
|
106,390
USD
|
|
|
2024-03-18 |
2023-01-09 |
S
Sale
|
Longpre Lara
CHIEF DEVELOPMENT OFFICER
Officer
|
1,003
-1.0%
20.62
20,684
USD
|
1,003
-1.0%
|
20.62
|
20,684
USD
|
|
|
2024-03-18 |
2023-01-09 |
S
Sale
|
Radovich Peter
PRESIDENT AND COO
Officer
|
1,379
-4.0%
20.62
28,438
USD
|
1,379
-4.0%
|
20.62
|
28,438
USD
|
|
|
2022-11-15 |
2022-11-15 |
S
Sale
|
O'Donnell Niall
Non-Executive Director
|
93,770
-5.5%
19.69
1,846,022
USD
|
93,770
-5.5%
|
19.69
|
1,846,022
USD
|
|
|
2022-11-15 |
2022-11-14 |
S
Sale
|
O'Donnell Niall
Non-Executive Director
|
32,109
-1.8%
19.60
629,423
USD
|
32,109
-1.8%
|
19.60
|
629,423
USD
|
|
|
2022-11-15 |
2022-11-11 |
S
Sale
|
O'Donnell Niall
Non-Executive Director
|
174,121
-9.1%
19.99
3,481,410
USD
|
174,121
-9.1%
|
19.99
|
3,481,410
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
6,243
-0.4%
24.47
152,766
USD
|
6,243
-0.4%
|
24.47
|
152,766
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
6,909
-0.4%
24.47
169,063
USD
|
6,909
-0.4%
|
24.47
|
169,063
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
155
-0.0%
25.08
3,887
USD
|
155
-0.0%
|
25.08
|
3,887
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
171
-0.0%
25.08
4,289
USD
|
171
-0.0%
|
25.08
|
4,289
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
11,868
-0.8%
25.29
300,142
USD
|
11,868
-0.8%
|
25.29
|
300,142
USD
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
Flynn James E
Major owner
|
13,132
-0.8%
25.29
332,108
USD
|
13,132
-0.8%
|
25.29
|
332,108
USD
|
|
|
2021-11-29 |
2021-11-26 |
B
Purchase
|
Clements Ian
Chief Financial Officer
Officer
|
750
+4.2%
13.90
10,425
USD
|
750
+4.2%
|
13.90
|
10,425
USD
|
|
|
2021-11-29 |
2021-11-24 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
7,000
+33.3%
14.40
100,800
USD
|
7,000
+33.3%
|
14.40
|
100,800
USD
|
|
|
2021-11-29 |
2021-11-24 |
B
Purchase
|
Clements Ian
Chief Financial Officer
Officer
|
700
+4.1%
14.40
10,080
USD
|
700
+4.1%
|
14.40
|
10,080
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Vig Pamela
Chief Scientific Officer
Officer
|
1,364
-12.4%
19.26
26,265
USD
|
1,364
-12.4%
|
19.26
|
26,265
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Longpre Lara
Chief Development Officer
Officer
|
961
-1.1%
19.26
18,505
USD
|
961
-1.1%
|
19.26
|
18,505
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Tucker Edwin Jonathan
Chief Medical Officer
Officer
|
1,364
-2.9%
19.26
26,265
USD
|
1,364
-2.9%
|
19.26
|
26,265
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Clements Ian
Chief Financial Officer
Officer
|
1,574
-8.6%
19.26
30,309
USD
|
1,574
-8.6%
|
19.26
|
30,309
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Peetz Christopher
President and CEO
Executive Director
|
3,672
-14.9%
19.26
70,708
USD
|
3,672
-14.9%
|
19.26
|
70,708
USD
|
|
|
2021-10-01 |
2021-10-01 |
S
Sale
|
Radovich Peter
Chief Operating Officer
Officer
|
1,364
-10.8%
19.26
26,265
USD
|
1,364
-10.8%
|
19.26
|
26,265
USD
|
|
|
2020-12-28 |
2020-12-23 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
2,000
+1.0%
18.60
37,200
USD
|
2,000
+1.0%
|
18.60
|
37,200
USD
|
|
|
2020-12-28 |
2020-12-23 |
B
Purchase
|
Clements Ian
Chief Financial Officer
Officer
|
1,562
+24.9%
18.65
29,131
USD
|
1,562
+24.9%
|
18.65
|
29,131
USD
|
|
|
2020-12-28 |
2020-12-23 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
3,000
+1.5%
18.76
56,280
USD
|
3,000
+1.5%
|
18.76
|
56,280
USD
|
|
|
2020-12-28 |
2020-12-23 |
B
Purchase
|
Clements Ian
Chief Financial Officer
Officer
|
908
+16.9%
18.55
16,843
USD
|
908
+16.9%
|
18.55
|
16,843
USD
|
|
|
2020-03-23 |
2020-03-20 |
B
Purchase
|
Tucker Edwin Jonathan
Chief Medical Officer
Officer
|
2,500
+71.4%
11.90
29,740
USD
|
2,500
+71.4%
|
11.90
|
29,740
USD
|
|
|
2020-03-23 |
2020-03-19 |
B
Purchase
|
Tucker Edwin Jonathan
Chief Medical Officer
Officer
|
2,000
+133.3%
9.91
19,818
USD
|
2,000
+133.3%
|
9.91
|
19,818
USD
|
|
|
2019-09-18 |
2019-09-17 |
B
Purchase
|
Fischer Laurent
|
1,648
+32.3%
9.37
15,435
USD
|
1,648
+32.3%
|
9.37
|
15,435
USD
|
|
|
2019-09-18 |
2019-09-16 |
B
Purchase
|
Fischer Laurent
|
452
+9.7%
9.47
4,280
USD
|
452
+9.7%
|
9.47
|
4,280
USD
|
|
|
2024-03-18 |
2019-09-10 |
B
Purchase
|
Longpre Lara
CHIEF DEVELOPMENT OFFICER
Officer
|
965
+0.9%
10.64
10,268
USD
|
965
+0.9%
|
10.64
|
10,268
USD
|
|
|
2019-09-12 |
2019-09-10 |
B
Purchase
|
Brege Laura
|
10,000
+inf%
11.22
112,200
USD
|
10,000
+inf%
|
11.22
|
112,200
USD
|
|
|
2019-09-10 |
2019-09-10 |
B
Purchase
|
Fischer Laurent
|
960
+26.0%
10.29
9,881
USD
|
960
+26.0%
|
10.29
|
9,881
USD
|
|
|
2019-09-10 |
2019-09-09 |
B
Purchase
|
Fischer Laurent
|
300
+8.8%
11.30
3,390
USD
|
300
+8.8%
|
11.30
|
3,390
USD
|
|
|
2019-09-10 |
2019-09-09 |
B
Purchase
|
Fischer Laurent
|
1,670
+97.1%
10.54
17,602
USD
|
1,670
+97.1%
|
10.54
|
17,602
USD
|
|
|
2019-09-10 |
2019-09-09 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
2,320
+1.2%
11.35
26,332
USD
|
2,320
+1.2%
|
11.35
|
26,332
USD
|
|
|
2019-09-10 |
2019-09-09 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
2,000
+1.0%
10.90
21,800
USD
|
2,000
+1.0%
|
10.90
|
21,800
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Fischer Laurent
|
1,720
+inf%
10.71
18,429
USD
|
1,720
+inf%
|
10.71
|
18,429
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Vig Pamela
Chief Scientific Officer
|
12
+0.8%
11.88
143
USD
|
12
+0.8%
|
11.88
|
143
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Vig Pamela
Chief Scientific Officer
|
1,600
+inf%
10.96
17,539
USD
|
1,600
+inf%
|
10.96
|
17,539
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Clements Ian
SVP Finance & Communications
|
2,199
+122.1%
11.87
26,102
USD
|
2,199
+122.1%
|
11.87
|
26,102
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Clements Ian
SVP Finance & Communications
|
1,801
+inf%
11.07
19,937
USD
|
1,801
+inf%
|
11.07
|
19,937
USD
|
|
|
2019-09-10 |
2019-09-06 |
B
Purchase
|
Peetz Christopher
President and CEO
Executive Director
|
4,750
+2.5%
10.91
51,806
USD
|
4,750
+2.5%
|
10.91
|
51,806
USD
|
|
|
2019-07-24 |
2019-07-22 |
B
Purchase
|
Frazier Life Sciences IX, L.P.
Major owner
|
450,000
+14.4%
15.00
6,750,000
USD
|
450,000
+14.4%
|
15.00
|
6,750,000
USD
|
|
|
2019-07-24 |
2019-07-22 |
B
Purchase
|
BARRIS PETER J
Major owner
|
450,000
+12.0%
15.00
6,750,000
USD
|
450,000
+12.0%
|
15.00
|
6,750,000
USD
|
|
